Evidence map›Paper›PMID 42831426›Full record

ArticleNucleic acids research2026

Size and sequence variation of the Lid of the Cas12a nuclease domain results in a nickase phenotype.

Ricardo Villegas Warren, Satoshi N Omura, Diana Leon Castro, Christian Südfeld, Maartje J Luteijn, Hayato Morinaga, Wakana J Inoue, Yutaro Shuto, Anne-Marie Kuijpers, Frank Meulewaeter and 5 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ricardo Villegas WarrenLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.
Satoshi N OmuraDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0003-2436-0847
Diana Leon CastroLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.
Christian SüdfeldLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.
Maartje J LuteijnLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.
Hayato MorinagaDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo 113-0033, Japan.
Wakana J InoueDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo 113-0033, Japan.
Yutaro ShutoDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo 113-0033, Japan.
Anne-Marie KuijpersBASF Belgium-Innovation Center Gent, Technologiepark-Zwijnaarde 101, 9052 Ghent, Belgium.
Frank MeulewaeterBASF Belgium-Innovation Center Gent, Technologiepark-Zwijnaarde 101, 9052 Ghent, Belgium.
David De VleesschauwerBASF Belgium-Innovation Center Gent, Technologiepark-Zwijnaarde 101, 9052 Ghent, Belgium.
Raymond H J StaalsLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.ORCID 0000-0002-5741-9457
Osamu NurekiDepartment of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo 113-0033, Japan.
Wen Y WuLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.ORCID 0000-0001-7147-7293
John van der OostLaboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, Netherlands.ORCID 0000-0001-5024-1871

Funding

Basis for Supporting Innovative Drug Discovery and Life Science Research JP23ama121002Basis for Supporting Innovative Drug Discovery and Life Science Research JP23ama121012Dutch Research Council 24bm1223004h0002Dutch Research Council bm1123046Dutch Research Council JP21km0908001Dutch Research Council VI.Vidi.203.074European Research Council ERC-AdG-834279NWO Spinoza SPI 93-537Supporting Drug Discovery and Life Science Research
6 · The paper itself

Abstract

CRISPR-Cas12a nucleases typically induce double-strand breaks (DSBs) to initiate genome editing. However, reliance on DSBs risks chromosomal rearrangements and unintended insertions or deletions at off-target sites. Therefore, engineering nickase variants that cleave only a single DNA strand might enable precise editing platforms. We describe an unbiased in vivo screen in Escherichia coli to identify LbCas12a nickase variants. We targeted the RuvC Lid domain for mutagenesis, hypothesizing that altering this region would disrupt the coordination of strand cleavage. While the screen produced many nickase variants with targeted point substitutions (Lid1), it also serendipitously yielded a variant (Lid2) with an unprecedented Lid domain in terms of size and sequence. Biochemical characterization confirms that Lid2 robustly nicks the non-target strand (NTS) with minor cleavage activity observed for the target strand (TS), accumulating predominantly nicked substrates. Cryo-electron microscopy (cryo-EM) at 2.5 Å resolution reveals that, in Lid2, the native α-helical Lid is replaced, uncoupling the concerted cleavage mechanism. Specifically, the remodeled Lid appears to stabilize the NTS in the active site, whereas it hampers the conformational transitions required for subsequent TS cleavage. This robust nickase-phenotype of this Cas12a variant expands the CRISPR-Cas toolbox and offers a new component for precise genome editing applications.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsDeoxyribonuclease IEndodeoxyribonucleasesCRISPR-Cas SystemsEscherichia coliModels, MolecularPhenotypeProtein DomainsBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsDeoxyribonuclease IEndodeoxyribonucleases

Identifiers

PMID42831426
PMCPMC13635745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.